Subsequently, we examined the functional role of NKG2D in human CD8+ T cell-mediated killing of neuroblastoma cells through an in vitro IFNγ ELISA assay conducted in the presence of an NKG2D-blocking antibody. Here, CD8A is linked to neuroblastoma.